FDA Clears Lumipulse as First Blood Test for Diagnosing Alzheimer Disease
The FDA-cleared Fujirebio’s Lumipulse Plasma Ratio blood test for the early detection of amyloid plaques associated with Alzheimer’s disease (AD). Lumipulse is the first in-vitro diagnostic (IVD) test used in […]
FDA Clears Lumipulse as First Blood Test for Diagnosing Alzheimer Disease Read More »